Abstract
Here we report the design of a general, redox-switchable organophosphorus alkyl radical trap that enables the synthesis of a broad range of C(sp3)-P(V) modalities. This "plug-and-play" approach relies upon in situ activation of alcohols and O═P(R2)H motifs, two broadly available and inexpensive sources of molecular complexity. The mild, photocatalytic deoxygenative strategy described herein allows for the direct conversion of sugars, nucleosides, and complex pharmaceutical architectures to their organophosphorus analogs. This includes the facile incorporation of medicinally relevant phosphonate ester prodrugs.
Funding Information
  • Danmarks Frie Forskningsfond (1056-00018B)
  • Genentech
  • Pfizer
  • Bristol-Myers Squibb
  • Merck
  • National Institute of General Medical Sciences (R35GM134897-04)
  • Janssen Pharmaceutica
  • Genmab
  • Princeton Catalysis Initiative

This publication has 65 references indexed in Scilit: